tility of oral contaceptive pills in incomplete abortion or miscarriage
Phase 4
- Conditions
- Health Condition 1: O046- Delayed or excessive hemorrhage following (induced) termination of pregnancy
- Registration Number
- CTRI/2024/07/070907
- Lead Sponsor
- AIIMS, Guwahati
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
RPOC on TVS in patients where expectant management is indicated with positive urinary pregnancy test
1 with incomplete miscarriage
2 following medical abortion.
3 following surgical evacuation
Exclusion Criteria
RPOC with any of the following clinical presentations:
1 more than mild vaginal bleeding
2 haemodynamic instability
3 signs of infection and/ or abdominal pain
4 Contraindications for OCP use
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of Participants With complete expulsion of RPOC at end of treatment as determined by TVSTimepoint: For Intervention group- Follow up at 4 weeks if no withdrawal <br/ ><br>bleeding or 1 week after withdrawal bleeding <br/ ><br>For control group- 2 weeks
- Secondary Outcome Measures
Name Time Method Percentage of participants requiring D and E at the end of treatment <br/ ><br>Timepoint: Intervention:4 weeks <br/ ><br>Control: 2 weeks;Percentage of participants with adverse effects (dizziness, weakness, vomiting, pain abdomen, signs of infection) <br/ ><br>Timepoint: Intervention: 4weeks <br/ ><br>Control: 2 weeks